New Era of Management for Diabetes and Hypertension

Journal Title: Advances in Diabetes & Endocrinology - Year 2018, Vol 3, Issue 1

Abstract

Looking back on the history of medical care, noteworthy diseases have changed along with long history. For recent years, metabolic syndrome (Met-S) has been increasing all over the world, which is an important health, medical and social problems [1,2]. Its prevalence has been higher in developed countries so far [3]. Nowadays, however, there has also been an increase in developing countries and appropriate action has been strongly needed. Basically, the pathophysiology of Met-S has been insulin resistance and impaired regulation of lipid metabolism is also associated [4-6]. Among them, the genetic predisposition is a factor of Met-S, and the prevalence of Met-S differs depending on the ethnic group [7]. For example, the HDL gene has strong relevance and may be inherited by 70% [8]. Furthermore, several factors have affected by lifestyle habitual factors, age, socioeconomic status, and so on

Authors and Affiliations

Hiroshi Bando

Keywords

Related Articles

Genetic Polymorphism and Risk of having Type 2 Diabetes in a Palestinian Population: A Study of 16 Gene Polymorphisms

Background: Type 2 Diabetes (T2D) is a multifactorial disease that encompasses environmental risk factors and the contribution of multiple genomic variants. Studies on the genetic components of T2D revealed many T2D-asso...

ERK5 and JNK Regulate the Expression of VCAM-1 Differentially in Insulin-and Tumor Necrosis Factor-α Stimulated Rat Aortic Endothelial Cells

Vascular Cell Adhesion Molecule-1 (VCAM-1) is a cell surface molecule that is expressed on vascular endothelial cells. One of the many functions of VCAM-1 is to interact with serum monocytes, causing them to adhere to th...

Conservative Management of Sclerosing Mucoepidermoid Carcinoma with Eosinophilia of the Thyroid Gland: 12 Years Follow-Up after an Atypical Initial Therapy

Objective: Sclerosing Mucoepidermoid Carcinomas (SMEC) are low-grade malignant tumors with both mucinous and squamous differentiation representing less than 1% of thyroid malignancies. SMEC are sometimes associated with...

New Reference Values for Thyrotropin Hormone in Diabetic Patients

Objective: The present study aimed to find out how prevalent the thyroid disorders and the association of thyroid function with cardiovascular risk factors in type 2 diabetic patients.. Material and methods: This is a re...

Triple Phase Response of Transient Hyponatremia or Secondary Adrenal Insufficiency? A Case Report

Hyponatremiais common in neurosurgical patients especially after pituitary surgery. It is the most common electrolyte abnormalityencountered in general hospital admissions. Diagnosis of the underlying cause can be challe...

Download PDF file
  • EP ID EP485385
  • DOI 10.13188/2475-5591.1000009
  • Views 124
  • Downloads 0

How To Cite

Hiroshi Bando (2018). New Era of Management for Diabetes and Hypertension. Advances in Diabetes & Endocrinology, 3(1), 1-3. https://europub.co.uk/articles/-A-485385